Jennifer Wiernas, OD
Optometrist · Fort Worth, TXNPI 1932685682
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $659 of the $798 with a category attached, or 82.5%. It is spread thinly across 11 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $241 and has fallen 92.3% since, to $19 in 2025. That places this record below the midpoint for optometrist clinicians in TX, where the typical reported total is $910.
Across 19 payments — averaging $42.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$184
- Alcon$162
- Johnson & Johnson Vision Care, Inc.$122
- Glaukos Corporation$115
- Bausch & Lomb Americas Inc.$53
- Carl Zeiss Meditec, Inc.$36
- plus $125 from 5 others
What the payments were for
- Consulting fees$12015%
- Food & beverage$65983%
- Gifts$192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 6 | $184 |
| Alcon | 2 | $162 |
| Johnson & Johnson Vision Care, Inc. | 1 | $122 |
| Glaukos Corporation | 1 | $115 |
| Bausch & Lomb Americas Inc. | 3 | $53 |
| Carl Zeiss Meditec, Inc. | 1 | $36 |
| Dompe US, Inc. | 1 | $31 |
| Avedro Inc. | 1 | $30 |
| Tarsus Pharmaceuticals, Inc. | 1 | $27 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Oyster Point Pharma, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$798 in reported general payments places this provider in the 45th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 20 | $879 |
| Cephalexin | 23 | $99 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $88 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Fort Worth
- Kenneth KingFort Worth$39K
- Robert ChuFort Worth$30K
- Jennifer DeakinsFort Worth$23K
- Derek CunninghamAustin$940K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$547K
- Luis RojasMcKinney$309K
- Emile FadelAustin$225K
- Bridgitte LeeHouston$222K
- Phillip BrunsonHouston$214K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.